Information Provided By:
Fly News Breaks for June 8, 2017
HOLX
Jun 8, 2017 | 07:54 EDT
Canaccord analyst Mark Massaro noted Hologix announced a label expansion approval for its 3D tomo mammography system to include breast cancer screening for women with dense breast tissue. Massaro views this as an incremental positive to the company's diversified business. Massaro reiterated his Buy rating and $53 price target on Hologix shares.
News For HOLX From the Last 2 Days
There are no results for your query HOLX